You're contacting media contact of this press release

Title: CoreAge Rx Adds Targeted Prebiotic and Probiotic Blend to Support Digestion for GLP-1 Users

Wichita Falls, TX, United States, 6th Aug 2026 - Digital health organization CoreAge Rx has introduced GLP-1 Support, a daily digestive supplement. The new product is designed specifically to help ease the gastrointestinal discomfort often reported by individuals taking GLP-1 receptor agonist medications, including tirzepatide and semaglutide. Formulated as a non-stimulant option, the capsule works to maintain gut microbiome balance and support natural bowel regularity without causing severe cramping.Medications in the GLP-1 category are known to delay gastric emptying. While this mechanism is central to their function, it can also disrupt standard digestive rhythms, leading to sluggish digestion, bloating, and occasional constipation. To help users navigate these physical changes, CoreAge Rx developed a specific blend of fermentable prebiotic fibers and targeted probiotic strains.The GLP-1 Support formula includes:Akkermansia muciniphila: Included to help maintain the integrity of the intestinal lining.Bifidobacterium infantis: Added to encourage general abdominal comfort.Clostridium butyricum: A strain that supports the production of butyrate, a short-chain fatty acid utilized by gut cells.Prebiotic Fiber Blend: Contains 211 mg of chicory root inulin and 100 mg of potato resistant starch to feed beneficial gut bacteria.To protect the live cultures from stomach acid, CoreAge Rx utilizes a vegetarian, delayed-release capsule that delivers the ingredients directly to the intestinal tract. The company recommends taking one capsule daily with eight ounces of water, which can be consumed with or without food. Users are advised to refrigerate the bottle after opening to maintain the potency of the bacterial strains.Manufactured in the United States, GLP-1 Support is availabl...

This press release is issued by King Newswire